Vinorelbine (VNR) by alternating intravenous (IV)/oral administration plus cisplatinum (CP) followed by oral VNR as first-line therapy of advanced non-small cell lung cancer (ANSCLC)

被引：0
|
作者：
Sperandi, Francesca
Melotti, Barbara
Giaquinta, Stefania
Piana, Edera
Pavesi, Lorenzo
Da Prada, Gian Antonio
Lelli, Giorgio
Martoni, Andrea Angelo
机构：
[1] St Orsola Marcello Malpighi Hosp, Med Oncol Unit, Bologna, Italy
[2] S Maugeri Fdn, Pavia, Italy
[3] Arcispedale St Anna, Ferrara, Italy
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：227 / 227
页数：1
相关论文
共 50 条
  • [41] First-Line Systemic Therapy for Non-Small Cell Lung Cancer
    Heist, Rebecca S.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2017, 31 (01) : 59 - +
  • [42] Non-small cell Lung Cancer Personalization of First-Line Therapy
    Schmale, Ine
    ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 (05)
  • [43] First-line treatment with vinorelbine (VNR) plus carboplatin (CBDCA) for patients with advanced non-small-cell lung cancer (NSCLC): MAP4/OP18 mRNA expression as marker predictive of response
    Galan, A.
    del Barco, S.
    Mendez, M.
    Esquerdo, G.
    Cerezuela, P.
    Huarriz, M.
    Bandres, E.
    Paules, A. B.
    Gayo, J.
    Garcia-Foncillas, J.
    EJC SUPPLEMENTS, 2007, 5 (04): : 376 - 376
  • [44] Immune checkpoint inhibitors in first-line therapy of advanced non-small cell lung cancer
    Remon, Jordi
    Besse, Benjamin
    CURRENT OPINION IN ONCOLOGY, 2017, 29 (02) : 97 - 104
  • [45] Docetaxel (Taxotere®) as first-line therapy of advanced non-small cell lung cancer (NSCLC)
    Manegold, C
    ONKOLOGIE, 2003, 26 : 26 - 32
  • [46] Gefitinib(Iressa) as first-line therapy in advanced non-small lung cancer
    Zimmermann, M
    Luthi, F
    Zouhair, A
    Bauer, J
    Leyvraz, S
    Stupp, R
    LUNG CANCER, 2005, 49 : S276 - S276
  • [47] Preliminary efficacy and safety of camrelizumab plus metronomic oral vinorelbine as first-line therapy for people aged 70 and above with advanced non-small cell lung cancer (NSCLC) from a phase II trial
    Li, Lin
    Zhang, Ping
    Gao, Jiayi
    Tang, Min
    Nie, Xin
    Ma, Di
    Zhao, Zhe
    Yuan, Yue
    Ding, Li
    Li, Chao
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [48] A randomized phase II trial of cisplatinum plus mitomycin-C plus vinorelbine and carboplatin plus vinorelbine in advanced non-small cell lung cancer
    Colleoni, M
    Vicario, G
    Pancheri, F
    Sgarbossa, G
    Nelli, P
    Manente, P
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1997, 10 (03) : 619 - 622
  • [49] Oral Metronomic Vinorelbine in Advanced Non-small Cell Lung Cancer Patients Unfit for Chemotherapy
    Banna, Giuseppe L.
    Camerini, Andrea
    Bronte, Giuseppe
    Anile, Giuseppe
    Addeo, Alfredo
    Rundo, Francesco
    Zanghi, Guido
    Lal, Rohit
    Libra, Massimo
    ANTICANCER RESEARCH, 2018, 38 (06) : 3689 - 3697
  • [50] EFFECTIVENESS OF FIRST-LINE PEMETREXED PLUS PLATINUM FOR ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER
    Brandao, M. D. R. A.
    Luis, M. S.
    Amaral, N. C.
    Cassiano Neves, M.
    Camacho, C.
    Rodrigues, A. C.
    Pousa, I.
    Oliveira, J.
    Azevedo, I.
    ANNALS OF ONCOLOGY, 2015, 26
12345